There is generally a moment in my office when it all clicks into focus for a patient receiving a new diagnosis of ...

The new pill is the first long-term daily pill licensed to treat the condition, and works by blocking specific hormones that ...

Endometriosis affects about 1 in 10 women. But women see seven physicians on average before they get diagnosed.

Relugolix–estradiol–norethisterone (also known as relugolix combination therapy or Ryeqo) is the first long-term daily ...

Endometriosis affects millions of people - and this new breakthrough treatment could be a game-changer for some ...

A new endometriosis pill, relugolix combination therapy (Ryeqo), has been approved for NHS use in England. Expected to ...

The new tablet, known as Ryeqo or relugolix-estradiol-norethisterone, has been approved to treat women of reproductive age ...

Endometriosis and fibroids are two of the most common health issues affecting women often leading to severe pain heavy ...

Multiple women’s health medications are set to become more affordable when they're added to the government-subsidised list of ...

The contraceptive pill Slinda, endometriosis treatment Ryego and an IVF drug will be made cheaper via the Pharmaceutical Benefits Scheme, the Albanese government will announce.